| scholarly article | Q13442814 |
| P50 | author | Ding-Shinn Chen | Q9367511 |
| Chen Pei-jer | Q39577955 | ||
| P2093 | author name string | Joseph Sung | |
| Junko Tanaka | |||
| Takaji Wakita | |||
| John Ward | |||
| Hong Soo Kim | |||
| Sheng-Nan Lu | |||
| Stephen Locarnini | |||
| Suzanne Wait | |||
| Jack Wallace | |||
| James Y Y Fung | |||
| Si-Hyun Bae | |||
| CEVHAP North Asia Workshop on Viral Hepatitis | |||
| P2507 | corrigendum / erratum | Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080] | Q57205274 |
| P433 | issue | 5 | |
| P921 | main subject | World Health Organization | Q7817 |
| viral hepatitis | Q1983841 | ||
| P304 | page(s) | 1073-1080 | |
| P577 | publication date | 2013-07-12 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia | |
| P478 | volume | 59 |
| Q30391932 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. |
| Q34137291 | Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit |
| Q52671501 | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. |
| Q38759805 | Emerging drugs for the treatment of hepatitis B. |
| Q35098577 | Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus |
| Q38218607 | Future treatments of cirrhosis |
| Q59355831 | Global HBV burden: guesstimates and facts |
| Q92222789 | HLA-DQB1/DRB1 Alleles Associate with Traditional Chinese Medicine Syndrome of Chronic Hepatitis B: A Potential Predictor of Progression |
| Q36345224 | Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments |
| Q42211720 | Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia |
| Q37642807 | Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients |
| Q57148631 | Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting |
| Q41687237 | Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection |
| Q57205274 | Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080] | main subject | P921 |
Search more.